Compare $GALT vs $RCEL | Chartloom

Compare

$GALT vs $RCEL

Galectin Therapeutics Inc · AVITA Medical Inc

GALT

Galectin Therapeutics Inc

RCEL

AVITA Medical Inc

Compare $GALT vs $RCEL

Comparing Galectin Therapeutics Inc and AVITA Medical Inc

GALTGalectin Therapeutics Inc

RCELAVITA Medical Inc

GALTGalectin Therapeutics Inc

Market cap

$259M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-2.7%

52W performance

-16.9%

FCF yield

-6.1%

RCELAVITA Medical Inc

Market cap

$407M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

4.05x

Rev growth (TTM)

1.0%

YTD performance

280.7%

52W performance

139.7%

FCF yield

-6.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

GALT

RCEL

Detailed metrics comparison

GALT

Galectin Therapeutics Inc

RCEL

AVITA Medical Inc

Market Cap

GALT$259M

RCEL$407M

Enterprise Value

GALT$384M

RCEL$444M

Price

GALT$3.94

RCEL$13.21

P/E Ratio

GALTN/A

RCELN/A

P/S Ratio

GALT0.00x

RCEL5.38x

EV/Sales

GALT0.00x

RCEL5.87x

EV/EBITDA

GALT0.00x

RCEL0.00x

P/B Ratio

GALT150.12x

RCEL87.44x

P/FCF Ratio

GALTN/A

RCELN/A

EV/FCF

GALT-24.16x

RCEL-17.54x

PEG Ratio

GALTN/A

RCELN/A

Forward P/E (NTM)

GALTN/A

RCELN/A

Forward P/S (NTM)

GALTN/A

RCEL4.05x

Revenue (TTM)

GALT$0

RCEL$76M

Revenue Growth (YoY)

GALTN/A

RCEL1.0%

Forward Rev Growth

GALT0.0%

RCEL20.3%

Gross Margin (TTM)

GALT0.0%

RCEL82.1%

Operating Margin (TTM)

GALT0.0%

RCEL0.0%

EBITDA Margin (TTM)

GALT0.0%

RCEL-41.9%

Net Margin (TTM)

GALT0.0%

RCEL-57.0%

FCF Margin (TTM)

GALTN/A

RCEL-33.5%

Net Income (TTM)

GALT$-28M

RCEL$-43M

FCF (TTM)

GALT$-16M

RCEL$-25M

EPS (TTM)

GALT-$0.43

RCEL-$1.40

ROE (TTM)

GALT-25862.0%

RCEL-33790.0%

ROA (TTM)

GALT-17683.0%

RCEL-7853.0%

ROIC (TTM)

GALT-11607.0%

RCEL-10295.0%

Cash

GALT$13M

RCEL$9M

Debt

GALT$138M

RCEL$47M

Net Cash/Debt

GALT$-124M

RCEL$-38M

Current Ratio (TTM)

GALT0.10x

RCEL0.41x

Quick Ratio (TTM)

GALT0.09x

RCEL0.31x

Debt/Equity (TTM)

GALT11.09x

RCEL9.39x

Debt/Assets (TTM)

GALT0.0%

RCEL0.0%

Interest Coverage (TTM)

GALTN/A

RCELN/A

Net Debt/EBITDA (TTM)

GALT0.00x

RCEL0.00x

Beta

GALT0.50

RCEL2.07

52W Performance

GALT-16.9%

RCEL139.7%

YTD Performance

GALT-2.7%

RCEL280.7%

% from 52W High

GALT-44.7%

RCEL-3.7%

% from 52W Low

GALT94.6%

RCEL310.2%

Asset Turnover (TTM)

GALT0.00x

RCEL1.38x

FCF Yield (TTM)

GALT-6.1%

RCEL-6.2%

Earnings Yield (TTM)

GALT-10.8%

RCEL-10.6%

Dividend Yield (TTM)

GALTN/A

RCELN/A

Rule of 40

GALT0.0

RCEL-32.5

EV/GP/RG

GALTN/A

RCEL0.22

Ticker research

View GALT research View RCEL research

Metric	GALT Galectin Therapeutics Inc	RCEL AVITA Medical Inc
Market & Valuation
Market Cap	$259M	$407M
Enterprise Value	$384M	$444M
Price	$3.94	$13.21
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	5.38x
EV/Sales	0.00x	5.87x
EV/EBITDA	0.00x	0.00x
P/B Ratio	150.12x	87.44x
P/FCF Ratio	N/A	N/A
EV/FCF	-24.16x	-17.54x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	4.05x
Revenue & Growth
Revenue (TTM)	$0	$76M
Revenue Growth (YoY)	N/A	1.0%
Forward Rev Growth	0.0%	20.3%
Profitability
Gross Margin (TTM)	0.0%	82.1%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-41.9%
Net Margin (TTM)	0.0%	-57.0%
FCF Margin (TTM)	N/A	-33.5%
Net Income (TTM)	$-28M	$-43M
FCF (TTM)	$-16M	$-25M
EPS (TTM)	-$0.43	-$1.40
ROE (TTM)	-25862.0%	-33790.0%
ROA (TTM)	-17683.0%	-7853.0%
ROIC (TTM)	-11607.0%	-10295.0%
Financial Health
Cash	$13M	$9M
Debt	$138M	$47M
Net Cash/Debt	$-124M	$-38M
Current Ratio (TTM)	0.10x	0.41x
Quick Ratio (TTM)	0.09x	0.31x
Debt/Equity (TTM)	11.09x	9.39x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.50	2.07
52W Performance	-16.9%	139.7%
YTD Performance	-2.7%	280.7%
% from 52W High	-44.7%	-3.7%
% from 52W Low	94.6%	310.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	1.38x
FCF Yield (TTM)	-6.1%	-6.2%
Earnings Yield (TTM)	-10.8%	-10.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-32.5
EV/GP/RG	N/A	0.22
Ticker research	View GALT research	View RCEL research

Valuation

P/S Ratio

GALT

0.00x

RCEL

5.38x

EV/FCF

GALT

-24.16x

RCEL

-17.54x

Growth & revenue

Revenue Growth TTM

RCEL

1.0%

Forward Revenue Growth

RCEL

20.3%

GALT

0.0%

Profitability & performance

Gross Margin

RCEL

82.1%

GALT

0.0%

ROE

GALT

-25862.0%

RCEL

-33790.0%

FCF Yield %

GALT

-6.1%

RCEL

-6.2%

52-Week Performance

RCEL

139.7%

GALT

-16.9%

Detailed metrics comparison

GALT

Galectin Therapeutics Inc

RCEL

AVITA Medical Inc

Market Cap

GALT$259M

RCEL$407M

Enterprise Value

GALT$384M

RCEL$444M

Price

GALT$3.94

RCEL$13.21

P/E Ratio

GALTN/A

RCELN/A

P/S Ratio

GALT0.00x

RCEL5.38x

EV/Sales

GALT0.00x

RCEL5.87x

EV/EBITDA

GALT0.00x

RCEL0.00x

P/B Ratio

GALT150.12x

RCEL87.44x

P/FCF Ratio

GALTN/A

RCELN/A

EV/FCF

GALT-24.16x

RCEL-17.54x

PEG Ratio

GALTN/A

RCELN/A

Forward P/E (NTM)

GALTN/A

RCELN/A

Forward P/S (NTM)

GALTN/A

RCEL4.05x

Revenue (TTM)

GALT$0

RCEL$76M

Revenue Growth (YoY)

GALTN/A

RCEL1.0%

Forward Rev Growth

GALT0.0%

RCEL20.3%

Gross Margin (TTM)

GALT0.0%

RCEL82.1%

Operating Margin (TTM)

GALT0.0%

RCEL0.0%

EBITDA Margin (TTM)

GALT0.0%

RCEL-41.9%

Net Margin (TTM)

GALT0.0%

RCEL-57.0%

FCF Margin (TTM)

GALTN/A

RCEL-33.5%

Net Income (TTM)

GALT$-28M

RCEL$-43M

FCF (TTM)

GALT$-16M

RCEL$-25M

EPS (TTM)

GALT-$0.43

RCEL-$1.40

ROE (TTM)

GALT-25862.0%

RCEL-33790.0%

ROA (TTM)

GALT-17683.0%

RCEL-7853.0%

ROIC (TTM)

GALT-11607.0%

RCEL-10295.0%

Cash

GALT$13M

RCEL$9M

Debt

GALT$138M

RCEL$47M

Net Cash/Debt

GALT$-124M

RCEL$-38M

Current Ratio (TTM)

GALT0.10x

RCEL0.41x

Quick Ratio (TTM)

GALT0.09x

RCEL0.31x

Debt/Equity (TTM)

GALT11.09x

RCEL9.39x

Debt/Assets (TTM)

GALT0.0%

RCEL0.0%

Interest Coverage (TTM)

GALTN/A

RCELN/A

Net Debt/EBITDA (TTM)

GALT0.00x

RCEL0.00x

Beta

GALT0.50

RCEL2.07

52W Performance

GALT-16.9%

RCEL139.7%

YTD Performance

GALT-2.7%

RCEL280.7%

% from 52W High

GALT-44.7%

RCEL-3.7%

% from 52W Low

GALT94.6%

RCEL310.2%

Asset Turnover (TTM)

GALT0.00x

RCEL1.38x

FCF Yield (TTM)

GALT-6.1%

RCEL-6.2%

Earnings Yield (TTM)

GALT-10.8%

RCEL-10.6%

Dividend Yield (TTM)

GALTN/A

RCELN/A

Rule of 40

GALT0.0

RCEL-32.5

EV/GP/RG

GALTN/A

RCEL0.22

Ticker research

View GALT research View RCEL research

Metric	GALT Galectin Therapeutics Inc	RCEL AVITA Medical Inc
Market & Valuation
Market Cap	$259M	$407M
Enterprise Value	$384M	$444M
Price	$3.94	$13.21
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	5.38x
EV/Sales	0.00x	5.87x
EV/EBITDA	0.00x	0.00x
P/B Ratio	150.12x	87.44x
P/FCF Ratio	N/A	N/A
EV/FCF	-24.16x	-17.54x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	4.05x
Revenue & Growth
Revenue (TTM)	$0	$76M
Revenue Growth (YoY)	N/A	1.0%
Forward Rev Growth	0.0%	20.3%
Profitability
Gross Margin (TTM)	0.0%	82.1%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-41.9%
Net Margin (TTM)	0.0%	-57.0%
FCF Margin (TTM)	N/A	-33.5%
Net Income (TTM)	$-28M	$-43M
FCF (TTM)	$-16M	$-25M
EPS (TTM)	-$0.43	-$1.40
ROE (TTM)	-25862.0%	-33790.0%
ROA (TTM)	-17683.0%	-7853.0%
ROIC (TTM)	-11607.0%	-10295.0%
Financial Health
Cash	$13M	$9M
Debt	$138M	$47M
Net Cash/Debt	$-124M	$-38M
Current Ratio (TTM)	0.10x	0.41x
Quick Ratio (TTM)	0.09x	0.31x
Debt/Equity (TTM)	11.09x	9.39x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.50	2.07
52W Performance	-16.9%	139.7%
YTD Performance	-2.7%	280.7%
% from 52W High	-44.7%	-3.7%
% from 52W Low	94.6%	310.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	1.38x
FCF Yield (TTM)	-6.1%	-6.2%
Earnings Yield (TTM)	-10.8%	-10.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-32.5
EV/GP/RG	N/A	0.22
Ticker research	View GALT research	View RCEL research